Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Sunitinib Before or After Surgery in Treating Patients With Metastatic Kidney Cancer [Phase 2]
This entry reports an ongoing Phase 2 clinical trial evaluating Sunitinib given before or after surgery in patients with metastatic renal ce…
-
CLINICAL_TRIALS research · 2013-08-12Clinical Trial Update: Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer [NA]
This clinical trial update describes using ultrasound to assess antiangiogenic therapy in patients with advanced renal cell carcinoma.
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 trial evaluating bevacizumab in combination with interleukin-2 for metastatic or recurrent renal cell carcinoma; results were posted…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Randomized Study of Sorafenib Dose Escalation in Patients With Previously Untreated Metastatic Renal Cell Carcinoma [Phase 2]
Phase 2 randomized dose-escalation trial of sorafenib in patients with previously untreated metastatic renal cell carcinoma. The study was t…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer [Phase 1]
A Phase 1 study evaluated intravenous interleukin-4 PE38KDEL cytotoxin in patients with recurrent or metastatic breast cancer, renal cell ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study Testing the Biologic Activity and Safety of a Immunotherapeutic in Patients With Newly Diagnosed Advanced Stage Kidney Cancer in Combination With a Marketed Renal Cell Carcinoma Treatment [Phase 2]
A Phase 2 trial evaluating the biologic activity and safety of an immunotherapeutic in newly diagnosed advanced renal cell carcinoma, tested…
-
CLINICAL_TRIALS trial_result · 2013-07-15Clinical Trial Update: Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers [Phase 1]
Phase 1 study evaluating the combination of nelfinavir and temsirolimus in patients with advanced cancers, including renal cell carcinoma, h…
-
CLINICAL_TRIALS withdrawal · 2013-07-11Clinical Trial Update: Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer [Phase 2]
A Phase 2 trial evaluating peripheral stem cell transplantation for metastatic or recurrent renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Low-dose IL-2 Plus IFN-alpha Immunotherapy as Adjuvant Treatment of Renal Carcinoma. [Phase 3]
A Phase 3 trial evaluating low-dose interleukin-2 plus interferon-alpha as adjuvant immunotherapy for renal cell carcinoma has completed.
-
CLINICAL_TRIALS withdrawal · 2013-07-10Clinical Trial Update: BAY 56-3722 in Treating Patients With Recurrent, Unresectable, or Metastatic Kidney Cancer [Phase 2]
A Phase 2 trial evaluating BAY 56-3722 for recurrent, unresectable, or metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS safety_alert · 2013-07-04Clinical Trial Update: Post Marketing Surveillance On The Safety And Tolerability Of Sunitinib Malate (Sutent) For Filipino Patients
This post-marketing surveillance study evaluated the safety and tolerability of Sunitinib Malate (Sutent) in Filipino patients with metastat…
-
CLINICAL_TRIALS research · 2013-07-03Clinical Trial Update: Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy [NA]
A clinical trial is evaluating segmental renal artery clamping during laparoscopic partial nephrectomy for kidney cancers; the current statu…
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Sorafenib and Interferon Alfa in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial evaluating sorafenib in combination with interferon alfa-2b for locally advanced or metastatic renal cell carcinoma; …
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Sorafenib Tosylate and Bevacizumab in Treating Patients With Advanced Kidney Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating the combination of sorafenib tosylate and bevacizumab in advanced renal cell carcinoma, with results post…
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Bryostatin 1 In Treating Patients With Progressive Kidney Cancer [Phase 2]
A Phase 2 trial evaluating Bryostatin-1 in patients with progressive kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-26Clinical Trial Update: Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial update evaluating a combination of biological therapy and chemotherapy for metastatic colorectal cancer and metas…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer [Phase 2]
Phase 2 clinical trial update of tanespimycin (17-N-Allylamino-17-Demethoxygeldanamycin) in patients with metastatic renal cell carcinoma; t…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer [Phase 2]
Phase 2 trial of flavopiridol for unresectable or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-21Clinical Trial Update: 6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating 6-Hydroxymethylacylfulvene (Irofulven) in patients with meta…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Phase I Study of Vorinostat and Sorafenib in Advanced Cancer [Phase 1]
Phase I study update of the combination of vorinostat and sorafenib in patients with advanced cancer, with completed status. Diseases includ…
-
CLINICAL_TRIALS trial_result · 2013-06-20Clinical Trial Update: Denileukin Diftitox in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer [Phase 2]
Phase 2 study of denileukin diftitox in metastatic melanoma or metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Arsenic Trioxide in Treating Patients With Metastatic Kidney Cancer [Phase 2]
A Phase 2 clinical trial evaluating arsenic trioxide for metastatic kidney cancer has completed.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Caspofungin Acetate in Treating Children With Fever and Neutropenia [NA]
An update on a completed clinical trial evaluating caspofungin acetate for treating infections in pediatric patients with fever and neutrope…
-
CLINICAL_TRIALS withdrawal · 2013-06-19Clinical Trial Update: Tivozanib + Gemcitabine in Metastatic RCC [Phase 2]
A Phase 2 trial of tivozanib plus gemcitabine in metastatic renal cell carcinoma has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma [Phase 3]
Phase 3 randomized trial comparing pazopanib to sunitinib in first-line locally advanced or metastatic renal cell carcinoma has completed, w…